Atria Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Sell
105,655
-40,415
-28% -$1.81M 0.05% 416
2026
Q1
$7.04M Buy
146,070
+13,354
+10% +$623K 0.08% 277
2025
Q4
$6.43M Buy
132,716
+15,416
+13% +$764K 0.07% 298
2025
Q3
$5.54M Sell
117,300
-16,347
-12% -$789K 0.06% 355
2025
Q2
$6.46M Buy
133,647
+14,475
+12% +$740K 0.08% 298
2025
Q1
$6.61M Buy
119,172
+13,139
+12% +$711K 0.08% 275
2024
Q4
$5.11M Sell
106,033
-1,263
-1% -$64.2K 0.06% 338
2024
Q3
$6.18M Buy
107,296
+701
+0.7% +$37.8K 0.08% 296
2024
Q2
$5.17M Buy
106,595
+7,717
+8% +$372K 0.07% 322
2024
Q1
$4.81M Buy
98,878
+23,463
+31% +$1.15M 0.07% 346
2023
Q4
$3.75M Buy
75,415
+624
+0.8% +$30.5K 0.06% 373
2023
Q3
$4.01M Buy
74,791
+9,694
+15% +$517K 0.07% 341
2023
Q2
$3.51M Buy
65,097
+9,217
+16% +$496K 0.06% 370
2023
Q1
$3.04M Buy
55,880
+20,084
+56% +$977K 0.06% 399
2022
Q4
$1.73M Buy
35,796
+8,166
+30% +$358K 0.04% 561
2022
Q3
$1.05M Sell
27,630
-16,245
-37% -$724K 0.02% 706
2022
Q2
$2.19M Buy
43,875
+1,146
+3% +$60.8K 0.05% 470
2022
Q1
$2.19M Buy
42,729
+1,483
+4% +$76.6K 0.04% 536
2021
Q4
$2.07M Buy
41,246
+115
+0.3% +$5.69K 0.04% 550
2021
Q3
$1.98M Buy
41,131
+5,970
+17% +$304K 0.04% 533
2021
Q2
$1.85M Buy
35,161
+6,701
+24% +$350K 0.04% 531
2021
Q1
$1.41M Buy
28,460
+1,521
+6% +$73.1K 0.03% 581
2020
Q4
$1.31M Buy
26,939
+2,571
+11% +$127K 0.03% 573
2020
Q3
$1.22M Buy
24,368
+3,901
+19% +$201K 0.04% 503
2020
Q2
$1.04M Buy
20,467
+3,235
+19% +$157K 0.04% 502
2020
Q1
$753K Buy
17,232
+2,597
+18% +$124K 0.06% 272
2019
Q4
$735K Buy
+14,635
New +$686K 0.02% 652
2019
Q3
– Sell
-5,325
Closed -$225K – 957
2019
Q2
$225K Buy
+5,325
New +$226K 0.01% 860
2018
Q4
– Sell
-8,957
Closed -$400K – 998
2018
Q3
$400K Buy
8,957
+367
+4% +$15.7K 0.02% 664
2018
Q2
$344K Sell
8,590
-2,165
-20% -$85.2K 0.02% 690
2018
Q1
$431K Buy
10,755
+1,011
+10% +$42.1K 0.02% 558
2017
Q4
$419K Sell
9,744
-1,686
-15% -$77.7K 0.02% 531
2017
Q3
$569K Buy
11,430
+3,339
+41% +$162K 0.03% 431
2017
Q2
$388K Buy
8,091
+705
+10% +$33.7K 0.02% 492
2017
Q1
$334K Buy
7,386
+602
+9% +$25.5K 0.02% 489
2016
Q4
$274K Buy
+6,784
New +$267K 0.02% 501
2016
Q1
– Sell
-5,593
Closed -$226K – 486
2015
Q4
$226K Sell
5,593
-507
-8% -$23.3K 0.02% 367
2015
Q3
$290K Buy
6,100
+1,120
+22% +$57K 0.04% 271
2015
Q2
$247K Buy
4,980
+592
+13% +$30K 0.03% 344
2015
Q1
$217K Buy
+4,388
New +$210K 0.02% 376

Other funds holding SNY

Atria Investments's SNY Position: Q2 2026 in Review

Atria Investments reduced its Sanofi (SNY) stake by 28% in Q2 2026, selling an estimated $1.81M and leaving 105,655 shares worth $4.51M. The position accounts for 0.05% of the portfolio, ranked #416.

Atria Investments first reported a position in SNY in Q1 2015 and has held it in 40 quarters since. The position peaked at $7.04M in Q1 2026. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Atria Investments held 105,655 shares of Sanofi worth $4.51M as of Q2 2026.
  • Atria Investments sold 40,415 Sanofi shares in Q2 2026, an estimated $1.81M.
  • Sanofi made up 0.05% of Atria Investments's portfolio in Q2 2026, its #416 holding.
  • Atria Investments first reported a position in Sanofi in Q1 2015 and has held it in 40 quarters since.
  • Atria Investments's Sanofi position peaked at $7.04M in Q1 2026.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.